206 related articles for article (PubMed ID: 29912667)
1. Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer.
Ying J; Xu T; Wang Q; Ye J; Lyu J
Epigenetics; 2018; 13(5):490-504. PubMed ID: 29912667
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic changes as prognostic predictors in endometrial carcinomas.
Farkas SA; Sorbe BG; Nilsson TK
Epigenetics; 2017 Jan; 12(1):19-26. PubMed ID: 27874289
[TBL] [Abstract][Full Text] [Related]
3. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.
Wang Q; Xu K; Tong Y; Dai X; Xu T; He D; Ying J
J Cell Mol Med; 2020 Apr; 24(8):4533-4546. PubMed ID: 32150330
[TBL] [Abstract][Full Text] [Related]
4. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez JN; Wentzensen N; Maurer MJ; Hawthorne KM; Voss JS; Kroneman TN; Famuyide AO; Clayton AC; Halling KC; Kerr SE; Cliby WA; Dowdy SC; Kipp BR; Mariani A; Oberg AL; Podratz KC; Shridhar V; Sherman ME
Gynecol Oncol; 2015 Apr; 137(1):14-22. PubMed ID: 25677060
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.
Ying J; Wang Q; Xu T; Lyu J
Cancer Med; 2018 Jun; 7(6):2601-2611. PubMed ID: 29665298
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis.
Ding W; Chen G; Shi T
Epigenetics; 2019 Jan; 14(1):67-80. PubMed ID: 30696380
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
Makabe T; Arai E; Hirano T; Ito N; Fukamachi Y; Takahashi Y; Hirasawa A; Yamagami W; Susumu N; Aoki D; Kanai Y
Carcinogenesis; 2019 Jul; 40(5):611-623. PubMed ID: 30850842
[TBL] [Abstract][Full Text] [Related]
9. Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA-sequencing and methylation modification data in endometrial cancer.
Zhou H; Zhang Y; Jin J; Shen K; Yang Y; Lao P
J Gene Med; 2024 Jan; 26(1):e3638. PubMed ID: 38011892
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
Wang Y; Liu D; Jin X; Song H; Lou G
Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
[TBL] [Abstract][Full Text] [Related]
11. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
12. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers.
Zighelboim I; Goodfellow PJ; Schmidt AP; Walls KC; Mallon MA; Mutch DG; Yan PS; Huang TH; Powell MA
Clin Cancer Res; 2007 May; 13(10):2882-9. PubMed ID: 17504987
[TBL] [Abstract][Full Text] [Related]
13. Construction of a nine DNA repair-related gene prognostic classifier to predict prognosis in patients with endometrial carcinoma.
Liu J; Jiang P; Chen X; Shen Y; Cui G; Ma Z; Zhao S; Zhang Y
BMC Cancer; 2021 Jan; 21(1):29. PubMed ID: 33407221
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data.
Huo X; Sun H; Cao D; Yang J; Peng P; Yu M; Shen K
Sci Rep; 2019 Jul; 9(1):9924. PubMed ID: 31289358
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of DNA content assessment in endometrial cancer.
Mauland KK; Wik E; Salvesen HB
Cytometry B Clin Cytom; 2014 May; 86(3):154-63. PubMed ID: 24532190
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
18. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
19. Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically.
Men C; Chai H; Song X; Li Y; Du H; Ren Q
J Gynecol Oncol; 2017 Nov; 28(6):e83. PubMed ID: 29027401
[TBL] [Abstract][Full Text] [Related]
20. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
